MRNA Jun 2024 140.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:40PM EDT. Market open.
| Previous Close | 8.66 |
| Open | 6.10 |
| Bid | 5.50 |
| Ask | 5.80 |
| Strike | 140.00 |
| Expire Date | 2024-06-28 |
| Day's Range | 5.00 - 6.10 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 258 |
ZacksModerna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Data from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against COVID-19 when compared with its previously approved bivalent COVID-19 vaccine.
Simply Wall St.Moderna (NASDAQ:MRNA) shareholders are still up 857% over 5 years despite pulling back 6.1% in the past week
Long term investing can be life changing when you buy and hold the truly great businesses. And highest quality...
ACCESSWIREModerna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation COVID-19 Vaccine
mRNA-1283 met its primary vaccine efficacy endpoint in a Phase 3 trial, demonstrating non-inferior vaccine efficacy against COVID-19 compared to Spikevax® in participants 12 years of age and older Higher efficacy was observed in mRNA-1283 compared ...
© 2024 Yahoo. All rights reserved.